Results for 'advances'
Find oncology podcasts about advances — interviews, panel discussions, and expert-led audio on cancer innovation. Open any episode for listening options and show notes; switch tabs to explore articles, partners, and community members.
Recent Advances and Future Directions in Oncology
Listen on Everand Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in acute myeloid leukemia, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung c…
Nov 23rd • 364 mins listen
Recent Advances and Real-World Implications in Chronic Lymphocytic Leukemia and Lymphomas
Listen on Everand Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas, multiple myeloma, genitourinary cancers, brea…
Mar 4th • 60 mins listen
Recent Advances and Real-World Implications in Multiple Myeloma
Listen on Everand Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas, multiple myeloma, genitourinary cancers,…
Mar 4th • 60 mins listen
Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.
City of Hope, Academic Research, CAR T-cell, Solid Tumor, Glioblastoma, brain tumor
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Christine Brown, Ph.D., Deputy Director of the T Cell Research Laboratory at City of Hope, joins Monty Pal, M.D., F.A.S.C.O., to discuss how years of research in glioblastoma, one of the most aggressive and difficult brain ca…
Apr 6th • 42 mins listen
Rethinking How We Track and Treat Cancer
diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen